As of November this year, based on Merit Medical Systems's latest financial report, the company's current EPS (TTM) is $2.69. In 2025, MMSI reported a per-share earnings of $2.17, which represents an increase compared to the EPS of $2.07 recorded in 2024. Merit Medical Systems's EPS for the quarterly period ending on Sep 30, 2026 was $0.71.
The yearly EPS in 2025 was $2.17, an increase of 4.8% compared to $2.07 recorded in 2024. For the quarter ending Sep 30, 2026, the EPS was $0.71, reflecting a 51.1% increase compared to the same quarter a year earlier. The trailing twelve months (TTM) EPS as of September 2026 is $2.69. In 2024, the annual EPS was $2.07, showing an increase of 26.2% compared to 2023.
Merit Medical Systems has recorded a growth in earnings per share of 51.1% over the past 12 months (YoY, quarterly). For the last three years, MMSI had an average yearly EPS growth of 18.3%. Over the last decade, MMSI had an average annual earnings per share growth of 14.9%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TFX Teleflex Incorporated | 18.48 | -1,462.4% | N/A | N/A |
| BSX Boston Scientific Corp | 18.59 | 55.6% | 63.3% | N/A |
| MDT Medtronic Plc | 24.78 | 3.3% | 9.8% | 6.9% |
| MMSI Merit Medical Systems Inc | 32.23 | 4.8% | 18.3% | N/A |
| JNJ Johnson & Johnson | 42.62 | 90.6% | 17.7% | 14.8% |
| EW Edwards Lifesciences Corp | 59.6 | -73.6% | -9.2% | 6.9% |
| ICUI ICU Medical Inc | 73.63 | 100.6% | N/A | -62.7% |
| ANGO Angiodynamics Inc | N/A | -6% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.